Saturday, 25 May 2019
Latest news
Main » Gilead buys into CAR-T with $11.9bn deal for Kite

Gilead buys into CAR-T with $11.9bn deal for Kite

30 August 2017

The institutional investor held 16,291 shares of the health care company at the end of 2016Q4, valued at $1.17M, up from 9,389 at the end of the previous reported quarter. Tristate Cap Hldgs Inc now has $603.41 million valuation.

In London, FTSE 100 is closed for the August Bank Holiday, while U.S. futures have the S&P 500 trading 0.5 points down; the Nasdaq is down 2.5m while the Dow Jones Industrial Index off 19 points. About 14,025 shares traded. Mattersight Corp (NASDAQ:MATR) has declined 29.56% since August 28, 2016 and is downtrending. It has outperformed by 75.03% the S&P500.

Bnp Paribas Arbitrage Sa decreased its stake in Gilead Sciences Inc (GILD) by 51.48% based on its latest 2016Q4 regulatory filing with the SEC. Following the completion of the tender offer, Gilead would purchase the remaining shares not tendered through a second-step merger at the same price at which the tender offer was made. On average, equities research analysts forecast that Kite Pharma, Inc. will post ($7.96) EPS for the current fiscal year.

"Gilead is a very patient, diligent party when it comes to looking at strategic transactions", a person familiar with the matter told Business Insider. Considering that the stock daily volume of 17.06 million shares, this represents a pretty noteworthy trading in volume size. It has underperformed by 38.50% the S&P500. Samlyn Capital Llc sold 995,754 shares as Sensata Technologies Hldg Nv (Call) (ST)'s stock declined 3.64%. Thermo Fisher Scientific Inc (NYSE:TMO) was raised too. The company's shares were given away at $120.09 per share worth to an income of some $750,683 on account of Kim Helen Susan. H.C. Wainwright maintained Kite Pharma Inc (NASDAQ:KITE) on Tuesday, February 28 with "Buy" rating.

GAM Holding AG cut its stake in Kite Pharma, Inc. Jefferies Group LLC reiterated a buy rating and issued a $135.00 price target (up from $121.00) on shares of Kite Pharma in a research report on Wednesday, August 9th. Kate Spade & Company had 26 analyst reports since August 6, 2015 according to SRatingsIntel. Kite said this month it could be ready for a launch as soon as September, sending the shares new records. On Tuesday, July 25 the stock rating was maintained by Mizuho with "Buy".

Investors sentiment increased to 0.91 in 2016 Q4. Its up 0.86, from 1.18 in 2016Q3. 120 funds opened positions while 190 raised stakes.

The stock of Kite Pharma Incorporated (NASDAQ:KITE) registered a decrease of 3.5% in short interest. Dsam Partners (London) invested in 1.11% or 89,502 shares. Redmond Asset Mgmt Lc holds 5,672 shares. Morgan Stanley owns 0% invested in Tristate Capital Holdings Inc (NASDAQ:TSC) for 65,695 shares.

There has been some selling insider activity on Kite Pharma, Inc. Edge Wealth Limited Liability Co holds 1.48% or 54,495 shares in its portfolio. Synovus Financial holds 77,225 shares or 0.13% of its portfolio. Pinebridge Invs L P holds 0.04% of its portfolio in Gilead Sciences, Inc. Bridgeway Mngmt Inc invested in 0.03% or 114,010 shares. Menora Mivtachim Holdings LTD. now owns 1,433,899 shares of the biopharmaceutical company's stock worth $112,547,000 after buying an additional 175,000 shares during the last quarter. More interesting news about Netflix, Inc. Kim Helen Susan sold $197,088 worth of Kite Pharma Inc (NASDAQ:KITE) on Monday, May 1. On a one to five ratings scale where 1.0 indicates a Strong Buy, 2.0 indicates a Buy, 3.0 a Hold, 4.0 a Sell and 5.0 a Stong Sell. Therefore 63% are positive. As per Wednesday, June 14, the company rating was maintained by William Blair.

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now. and Gilead Sciences wasn't one of them! The company was initiated on Thursday, June 2 by Raymond James. The rating was maintained by Cowen & Co on Tuesday, April 19 with "Outperform". Wedbush upgraded the shares of KITE in report on Tuesday, August 29 to "Neutral" rating. (NASDAQ:GILD) on Tuesday, May 9.

Gilead buys into CAR-T with $11.9bn deal for Kite